Champions Oncology (CSBR) Return on Assets (2016 - 2025)
Historic Return on Assets for Champions Oncology (CSBR) over the last 15 years, with Q4 2025 value amounting to 0.08%.
- Champions Oncology's Return on Assets rose 1000.0% to 0.08% in Q4 2025 from the same period last year, while for Oct 2025 it was 0.08%, marking a year-over-year increase of 1000.0%. This contributed to the annual value of 0.16% for FY2025, which is 4000.0% up from last year.
- Latest data reveals that Champions Oncology reported Return on Assets of 0.08% as of Q4 2025, which was up 1000.0% from 0.09% recorded in Q3 2025.
- Champions Oncology's Return on Assets' 5-year high stood at 0.23% during Q1 2025, with a 5-year trough of 0.35% in Q1 2024.
- Its 5-year average for Return on Assets is 0.05%, with a median of 0.0% in 2021.
- Its Return on Assets has fluctuated over the past 5 years, first tumbled by -3300bps in 2023, then surged by 5800bps in 2025.
- Champions Oncology's Return on Assets (Quarter) stood at 0.01% in 2021, then tumbled by -78bps to 0.0% in 2022, then plummeted by -10948bps to 0.33% in 2023, then surged by 93bps to 0.02% in 2024, then soared by 436bps to 0.08% in 2025.
- Its last three reported values are 0.08% in Q4 2025, 0.09% for Q3 2025, and 0.15% during Q2 2025.